Search Results - "Parshottham, Sapna"

Phase I Study of the T-Cell Receptor-like Antibody, Hu8F4 in Patients with Relapsed and Refractory Myeloid Malignancies by Kadia, Tapan M., Kantarjian, Hagop, Alatrash, Gheath, Sergeeva, Anna, He, Hong, St. John, Lisa, Koppikar, Priya, Kerros, Celine, Clise-Dwyer, Karen, Ruissard, Kathryn, Maiti, Abhishek, DiNardo, Courtney D., Jabbour, Elias, Verstovsek, Srdan, Pemmaraju, Naveen, Jain, Nitin, Issa, Ghayas C., Garcia-Manero, Guillermo, Montalban-Bravo, Guillermo, Shastri, Aditi, Couriel, Daniel R., Pinsoy, Maria Rhona, Parshottham, Sapna, Champlin, Richard E., Cortes, Jorge, Molldrem, Jeffrey J.

“…Background: Relapse after conventional chemotherapy for newly diagnosed AML is responsible for the majority of treatment failure. Relapsed (R/R) disease is…”
Get full text

Early Intervention and Favorable Biologic Effects of Personalized Neoantigen Vaccines on the Tumor Immune Microenvironment in Smoldering Waldenstrom Macroglobulinemia by Szymura, Szymon, Cha, Soungchul, Wang, Lin, Zhang, Tiantian, Dong, Zhenyuan, Anderson, Aaron, Oh, Elizabeth, Wang, Zhe, Lee, Vincent, Parshottham, Sapna, Rao, Sheetal, Olsem, Jasper B, Crumpton, Brandon N, Lee, Hans C., Manasanch, Elisabet E., Neelapu, Sattva S., Thomas, Sheeba K., Kwak, Larry W.

“…Lymphoplasmacytic lymphoma (LPL) is an incurable low-grade B-cell lymphoma, characterized by the presence of clonal tumor cells infiltrating the bone marrow…”
Get full text